The bladder detrusor muscle is normally relaxed and it expands to accommodate increasing volumes of urine during filling until the need to void, at which time it contracts to empty the urine out of the bladder. The sensation of “fullness” typically occurs when the bladder is about 50% full and the urge to urinate (void) occurs when the bladder is about 75% full. In healthy people, the initiation of voiding is controllable even when the bladder holds more than 75% of its maximum capacity.

In people with overactive bladder (OAB), the detrusor muscle contracts spastically, resulting in high bladder pressure and a sudden urge to urinate (urgency). When the urge is not suppressed, it leads to involuntary loss of urine (incontinence). There are many causes of OAB and timely and correct diagnosis is often hard to achieve.

There are three symptoms associated with an overactive bladder:

  • Frequency (frequent urination, including at night)
  • Urgency (urgent need to urinate)
  • Urge incontinence (strong need to urinate followed by leaking or involuntary emptying)

People with OAB often experience urgency and incontinence at inconvenient and unpredictable times. It interferes with work, daily routine, intimacy and sexual function. It can cause embarrassment, social isolation, and can diminish self-esteem and quality of life.

OAB affects millions of people worldwide, and both sexes and all age groups may be affected. The overall prevalence of OAB in the US is similar between men (16.0%) and women (16.9%), but with different symptoms and severity [1].

OAB affects as many as 34 million people in the United States and its socioeconomic burden is estimated to be more than 12.6 billion dollars annually [2].

Diagnosis

Detrusor overactivity is a urodynamic observation characterized by involuntary detrusor contractions during the filling phase. The cystometrography (CMG), also known as filling cystometry, is the component of the urodynamic test that is used to assess the bladder during filling. A CMG provides information on the pressure/volume relationship of the bladder when you first feel the need to urinate, when you are able to sense fullness, and when your bladder is completely full.

NIRS Application

Urodynamix is currently conducting studies to examine the use of near infrared spectroscopy (NIRS) technology to aid in the diagnosis of OAB.

  

References:

[1] Stewart WF, Van Rooyen JB, Cundiff GW, Abrams P, Herzog AR, Corey R, Hunt TL, Wein AJ. Prevalence and burden of overactive bladder in the United States. World J Urol. 2003 May;20(6):327-36. Epub 2002 Nov 15.

[2] Tubaro A, Palleschi G. Overactive bladder: epidemiology and social impact. Curr Opin Obstet Gynecol. 2005 Oct;17(5):507-11.